Exact Sciences Corporation (EXAS) Social Stream
EXACT SCIENCES CORP (EXAS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EXAS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 12 | $165 | $95 | $143.583 | $37.89 | 278.95% |
| 2021-12-08 | 13 | $163 | $95 | $140.25 | $37.89 | 270.15% |
| 2022-01-04 | 13 | $163 | $95 | $139.25 | $37.89 | 267.51% |
| 2022-01-06 | 13 | $163 | $95 | $138 | $37.89 | 264.21% |
| 2022-01-18 | 13 | $163 | $95 | $136.5 | $37.89 | 260.25% |
| 2022-02-23 | 12 | $160 | $90 | $130.454 | $37.89 | 244.3% |
| 2022-02-24 | 12 | $160 | $90 | $125 | $37.89 | 229.9% |
| 2022-04-26 | 12 | $160 | $90 | $124.09 | $37.89 | 227.5% |
| 2022-04-28 | 12 | $160 | $65 | $104.714 | $37.89 | 176.36% |
| 2022-06-03 | 12 | $160 | $50 | $98.4 | $37.89 | 159.7% |
| 2022-07-19 | 11 | $160 | $50 | $89.571 | $37.89 | 136.4% |
| 2022-08-03 | 12 | $95 | $50 | $79.083 | $37.89 | 108.72% |
| 2022-08-13 | 13 | $95 | $50 | $71.307 | $37.89 | 88.19% |
| 2022-09-17 | 13 | $95 | $40 | $70.538 | $37.89 | 86.17% |
The Trend in the Analyst Price Target
Over the past 35 weeks, EXAS's average price target has gone down $65.96.
Over the past 45 weeks, EXAS's average upside potential has been 75.79%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-08 | 13 | 163 | 95 | 140.250 | 86.26 | 62.59% |
| 2022-01-18 | 12 | 163 | 95 | 136.500 | 77.42 | 76.31% |
| 2022-02-23 | 12 | 160 | 90 | 130.454 | 68.99 | 89.09% |
| 2022-06-03 | 12 | 160 | 50 | 98.400 | 47.55 | 106.94% |
| 2022-08-17 | 13 | 95 | 40 | 70.538 | 39.56 | 78.31% |
EXAS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.23 | 11 | 1 | 1 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
EXAS's average broker recommendation rating improved by 0.02 over the prior 153 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- EXACT SCIENCES CORP's upside potential (average analyst target price relative to current price) is higher than 1695.3% of all US stocks.
- In the context of all US stocks, EXACT SCIENCES CORP's average analyst price target is greater than 1597.62% of them.
- In the context of Healthcare stocks, EXACT SCIENCES CORP's number of analysts covering the stock is greater than 1740.99% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, EXACT SCIENCES CORP's variance in analysts' estimates is lower than -1362.12% of them.
Stocks similar to EXACT SCIENCES CORP in the Business Services industry regarding analyst recommendations and price targets are CRL, ALLE, and ZEN.
View All Top Stocks by Price Target
Is EXAS a Buy, Hold or Sell? See the POWR Ratings now!